Guidelines for Empiric Antimicrobial Prescribing in Community-Acquired Pneumonia

This publication has 65 references indexed in Scilit:

• Emergence of Macrolide Resistance during Treatment of Pneumococcal Pneumonia
  New England Journal of Medicine, 2002
• Efficacies of ABT-773, a New Ketolide, against Experimental Bacterial Infections
  Antimicrobial Agents and Chemotherapy, 2001
• Legionella as a Cause of Severe Pneumonia
  Seminars in Respiratory and Critical Care Medicine, 2000
• Bacteremic Pneumonia Due to Multidrug-Resistant Pneumococci in 3 Patients Treated Unsuccessfully with Azithromycin and Successfully with Levofloxacin
  Clinical Infectious Diseases, 2000
• Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
  Clinical Infectious Diseases, 2000
• Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society
  Clinical Infectious Diseases, 2000
• Clinical Characteristics of Chlamydia pneumoniae Infection as the Sole Cause of Community‐Acquired Pneumonia
  Clinical Infectious Diseases, 1999
• Legionellosis
  New England Journal of Medicine, 1997
• Severe Community-Acquired Pneumonia: A Possible Role for Chlamydia pneumoniae
  Respiration, 1996
• Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin
  European Journal of Clinical Microbiology & Infectious Diseases, 1990